Mulpleo is a medicine used to prevent excessive bleeding in adults with thrombocytopenia due to long-standing liver disease. Patients with thrombocytopenia have reduced number of platelets (components in the blood that help it to clot), which can cause excessive bleeding. The medicine is for use in patients having an invasive procedure (a medical procedure that involves cutting into or puncturing the skin or inserting instruments into the body). Mulpleo contains the active substance lusutrombopag.
Therapeutic Indication
### Therapeutic indication Mulpleo is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease undergoing invasive procedures
Therapeutic Area (MeSH)
ATC Code
B02BX
ATC Item
其它系统止血药
Pharmacotherapeutic Group
Antihemorrhagics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Lusutrombopag | N/A | 芦曲泊帕 |
EMA Name
Mulpleo (previously Lusutrombopag Shionogi)
Medicine Name
Mulpleo (previously Lusutrombopag Shionogi)
Aliases
N/ANo risk management plan link.
